GT Biopharma Stock Quote GTBP - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

3.7516

Bid

3.53

Ask

4.12

Volume

0.00 Day's Range 0.00

3.52 52 Week Range 16.11

Market Cap

5.177M

Previous Close

3.7516

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

19,203

Shares Outstanding

1,380,633

Dividend Yield

PE Ratio

-0.68

Earnings Per Share (EPS)

-5.5

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $3.75. Over the last year, GT Biopharma shares have traded in a share price range of $ 3.52 to $ 16.11.

GT Biopharma currently has 1,380,633 shares outstanding. The market capitalization of GT Biopharma is $5.18 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.68.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0484	-1.27368421053	3.8	3.88	3.53	4717	3.69329232	CS
4	-0.8284	-18.0873362445	4.58	4.77	3.53	6931	4.03060649	CS
12	-1.7864	-32.2571325388	5.538	6	3.52	19203	4.79619205	CS
26	-3.5984	-48.9578231293	7.35	9.9	3.52	86270	6.88357931	CS
52	-6.7484	-64.2704761905	10.5	16.11	3.52	227295	8.62111513	CS
156	-342.1484	-98.9154090778	345.9	591.993	3.52	215904	140.34049011	CS
260	-161.2484	-97.7263030303	165	591.993	3.52	245191	154.34711674	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TVGNTevogen Bio Holdings Inc	$ 1.57 (84.71%)	3.45M
PEGYPineapple Energy Inc	$ 0.0875 (68.59%)	44.24M
FRGTFreight Technologies Inc	$ 1.29 (41.18%)	6.11M
BIAFbioAffinity Technologies Inc	$ 3.16 (31.12%)	28
GGLLDirexion Daily GOOGL Bull 2X ETF	$ 44.55 (23.68%)	7.66k
ZENVZenvia Inc	$ 1.67 (-24.09%)	5
AHGAkso Health Group	$ 0.60 (-22.08%)	10
VINCVincerx Inc	$ 0.7134 (-20.44%)	149.07k
ANLAdlai Nortye Ltd	$ 10.80 (-19.76%)	2
NSYSNortech Systems Inc	$ 14.00 (-19.08%)	2
PEGYPineapple Energy Inc	$ 0.0875 (68.59%)	44.24M
FRGTFreight Technologies Inc	$ 1.29 (41.18%)	6.11M
IVPInspire Veterinary Partners Inc	$ 0.0439 (15.22%)	4.81M
KTRAKintara Therapeutics Inc	$ 0.184 (16.46%)	3.85M
TVGNTevogen Bio Holdings Inc	$ 1.57 (84.71%)	3.45M